Azitra Inc(AZTR) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates BRANFORD, Conn. — Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the three months ended March 31, 2024, and provided a business update. Q1 2024 and Recent Business Highlights ● Advanced ATR-12's Phase 1b trial, activating sites, advancing central IRB approval, and identifying init ...